79 related articles for article (PubMed ID: 38632244)
21. AP-1 subunits converge promiscuously at enhancers to potentiate transcription.
Seo J; Koçak DD; Bartelt LC; Williams CA; Barrera A; Gersbach CA; Reddy TE
Genome Res; 2021 Apr; 31(4):538-550. PubMed ID: 33674350
[TBL] [Abstract][Full Text] [Related]
22. Taxane-induced Attenuation of the CXCR2/BCL-2 Axis Sensitizes Prostate Cancer to Platinum-based Treatment.
Ruiz de Porras V; Wang XC; Palomero L; Marin-Aguilera M; Solé-Blanch C; Indacochea A; Jimenez N; Bystrup S; Bakht M; Conteduca V; Piulats JM; Buisan O; Suarez JF; Pardo JC; Castro E; Olmos D; Beltran H; Mellado B; Martinez-Balibrea E; Font A; Aytes A
Eur Urol; 2021 Jun; 79(6):722-733. PubMed ID: 33153817
[TBL] [Abstract][Full Text] [Related]
23. LINC00662 promotes cell proliferation, migration and invasion of melanoma by sponging miR-890 to upregulate ELK3.
Xia XQ; Lu WL; Ye YY; Chen J
Eur Rev Med Pharmacol Sci; 2020 Aug; 24(16):8429-8438. PubMed ID: 32894549
[TBL] [Abstract][Full Text] [Related]
24. AR phosphorylation and CHK2 kinase activity regulates IR-stabilized AR-CHK2 interaction and prostate cancer survival.
Ta HQ; Dworak N; Ivey ML; Roller DG; Gioeli D
Elife; 2020 Jun; 9():. PubMed ID: 32579110
[TBL] [Abstract][Full Text] [Related]
25. SPOP and cancer: a systematic review.
Clark A; Burleson M
Am J Cancer Res; 2020; 10(3):704-726. PubMed ID: 32266086
[TBL] [Abstract][Full Text] [Related]
26. Silencing of ELK3 Induces S-M Phase Arrest and Apoptosis and Upregulates SERPINE1 Expression Reducing Migration in Prostate Cancer Cells.
Mao Y; Li W; Hua B; Gu X; Pan W; Chen Q; Xu B; Wang Z; Lu C
Biomed Res Int; 2020; 2020():2406159. PubMed ID: 32104682
[TBL] [Abstract][Full Text] [Related]
27. Prostate Cancer-associated SPOP mutations enhance cancer cell survival and docetaxel resistance by upregulating Caprin1-dependent stress granule assembly.
Shi Q; Zhu Y; Ma J; Chang K; Ding D; Bai Y; Gao K; Zhang P; Mo R; Feng K; Zhao X; Zhang L; Sun H; Jiao D; Chen Y; Sun Y; Zhao SM; Huang H; Li Y; Ren S; Wang C
Mol Cancer; 2019 Nov; 18(1):170. PubMed ID: 31771591
[TBL] [Abstract][Full Text] [Related]
28. Long Non-Coding RNA LINC00525 Promotes the Stemness and Chemoresistance of Colorectal Cancer by Targeting miR-507/ELK3 Axis.
Wang S; Li J; Yang X
Int J Stem Cells; 2019 Jul; 12(2):347-359. PubMed ID: 31242722
[TBL] [Abstract][Full Text] [Related]
29. RSK2-Mediated ELK3 Activation Enhances Cell Transformation and Breast Cancer Cell Growth by Regulation of c-fos Promoter Activity.
Yoo SM; Lee CJ; An HJ; Lee JY; Lee HS; Kang HC; Cho SJ; Kim SM; Park J; Kim DJ; Cho YY
Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31018569
[TBL] [Abstract][Full Text] [Related]
30. SPOP Promotes Nanog Destruction to Suppress Stem Cell Traits and Prostate Cancer Progression.
Zhang J; Chen M; Zhu Y; Dai X; Dang F; Ren J; Ren S; Shulga YV; Beca F; Gan W; Wu F; Lin YM; Zhou X; DeCaprio JA; Beck AH; Lu KP; Huang J; Zhao C; Sun Y; Gao X; Pandolfi PP; Wei W
Dev Cell; 2019 Feb; 48(3):329-344.e5. PubMed ID: 30595538
[TBL] [Abstract][Full Text] [Related]
31. Taxane resistance in castration-resistant prostate cancer: mechanisms and therapeutic strategies.
Bumbaca B; Li W
Acta Pharm Sin B; 2018 Jul; 8(4):518-529. PubMed ID: 30109177
[TBL] [Abstract][Full Text] [Related]
32. SPOP promotes ATF2 ubiquitination and degradation to suppress prostate cancer progression.
Ma J; Chang K; Peng J; Shi Q; Gan H; Gao K; Feng K; Xu F; Zhang H; Dai B; Zhu Y; Shi G; Shen Y; Zhu Y; Qin X; Li Y; Zhang P; Ye D; Wang C
J Exp Clin Cancer Res; 2018 Jul; 37(1):145. PubMed ID: 29996942
[TBL] [Abstract][Full Text] [Related]
33. Concise Review: Prostate Cancer Stem Cells: Current Understanding.
Skvortsov S; Skvortsova II; Tang DG; Dubrovska A
Stem Cells; 2018 Oct; 36(10):1457-1474. PubMed ID: 29845679
[TBL] [Abstract][Full Text] [Related]
34. Kaempferol targeting on the fibroblast growth factor receptor 3-ribosomal S6 kinase 2 signaling axis prevents the development of rheumatoid arthritis.
Lee CJ; Moon SJ; Jeong JH; Lee S; Lee MH; Yoo SM; Lee HS; Kang HC; Lee JY; Lee WS; Lee HJ; Kim EK; Jhun JY; Cho ML; Min JK; Cho YY
Cell Death Dis; 2018 Mar; 9(3):401. PubMed ID: 29540697
[TBL] [Abstract][Full Text] [Related]
35. Functional analysis of Cullin 3 E3 ligases in tumorigenesis.
Cheng J; Guo J; Wang Z; North BJ; Tao K; Dai X; Wei W
Biochim Biophys Acta Rev Cancer; 2018 Jan; 1869(1):11-28. PubMed ID: 29128526
[TBL] [Abstract][Full Text] [Related]
36. Prostate cancer-associated SPOP mutations confer resistance to BET inhibitors through stabilization of BRD4.
Dai X; Gan W; Li X; Wang S; Zhang W; Huang L; Liu S; Zhong Q; Guo J; Zhang J; Chen T; Shimizu K; Beca F; Blattner M; Vasudevan D; Buckley DL; Qi J; Buser L; Liu P; Inuzuka H; Beck AH; Wang L; Wild PJ; Garraway LA; Rubin MA; Barbieri CE; Wong KK; Muthuswamy SK; Huang J; Chen Y; Bradner JE; Wei W
Nat Med; 2017 Sep; 23(9):1063-1071. PubMed ID: 28805820
[TBL] [Abstract][Full Text] [Related]
37. Involvement of c-Fos in cell proliferation, migration, and invasion in osteosarcoma cells accompanied by altered expression of Wnt2 and Fzd9.
Wang Q; Liu H; Wang Q; Zhou F; Liu Y; Zhang Y; Ding H; Yuan M; Li F; Chen Y
PLoS One; 2017; 12(6):e0180558. PubMed ID: 28665975
[TBL] [Abstract][Full Text] [Related]
38. EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part II: Treatment of Relapsing, Metastatic, and Castration-Resistant Prostate Cancer.
Cornford P; Bellmunt J; Bolla M; Briers E; De Santis M; Gross T; Henry AM; Joniau S; Lam TB; Mason MD; van der Poel HG; van der Kwast TH; Rouvière O; Wiegel T; Mottet N
Eur Urol; 2017 Apr; 71(4):630-642. PubMed ID: 27591931
[TBL] [Abstract][Full Text] [Related]
39. Loss of SLCO1B3 drives taxane resistance in prostate cancer.
de Morrée ES; Böttcher R; van Soest RJ; Aghai A; de Ridder CM; Gibson AA; Mathijssen RH; Burger H; Wiemer EA; Sparreboom A; de Wit R; van Weerden WM
Br J Cancer; 2016 Sep; 115(6):674-81. PubMed ID: 27537383
[TBL] [Abstract][Full Text] [Related]
40. XRP44X, an Inhibitor of Ras/Erk Activation of the Transcription Factor Elk3, Inhibits Tumour Growth and Metastasis in Mice.
Semenchenko K; Wasylyk C; Cheung H; Tourrette Y; Maas P; Schalken JA; van der Pluijm G; Wasylyk B
PLoS One; 2016; 11(7):e0159531. PubMed ID: 27427904
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
